Mohammad Obaidul Hoque
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Genomics, phytochemicals, and oxidative stress
Papers in
-
- Cancer Genomics and Diagnostics 13
-
- Epigenetics and DNA Methylation 62
- Cancer-related gene regulation 35
- RNA modifications and cancer 23
- Mitochondrial Function and Pathology 9
- Co-authors
- David SidranskyJoseph A. CalifanoMariana BraitWilliam H. WestraCármen JerónimoEli RosenbaumShahnaz BegumRui Henrique
- Journals
- Cancer Research (13 papers)Clinical Cancer Research (11 papers)International Journal of Cancer (8 papers)PLoS ONE (6 papers)Cancers (4 papers)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Mohammad Obaidul Hoque
130 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 2.0k
- Molecular Biology 5.9k
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.7k
- Otorhinolaryngology 177
Countries citing papers authored by Mohammad Obaidul Hoque
This map shows the geographic impact of Mohammad Obaidul Hoque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Obaidul Hoque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Obaidul Hoque more than expected).
Fields of papers citing papers by Mohammad Obaidul Hoque
This network shows the impact of papers produced by Mohammad Obaidul Hoque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Obaidul Hoque. The network helps show where Mohammad Obaidul Hoque may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Obaidul Hoque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2017 | 56 | |
| 3 | 2017 | 126 | |
| 4 | 2017 | 85 | |
| 5 | 2015 | 43 | |
| 6 | 2014 | 104 | |
| 7 | 2013 | 4 | |
| 8 | 2011 | 104 | |
| 9 | 2011 | 70 | |
| 10 | 2010 | 92 | |
| 11 | GULP1, a potential tumor suppressor gene in ovarian tumors and its utility as a biomarker | 2010 | 2 |
| 12 | 2009 | 57 | |
| 13 | 2009 | 59 | |
| 14 | 2008 | 115 | |
| 15 | 2008 | 105 | |
| 16 | Changes in CpG islands methylation patterns during ductal breast carcinoma progression. | 2008 | 1 |
| 17 | 2006 | 37 | |
| 18 | 2006 | 93 | |
| 19 | 2006 | 47 | |
| 20 | 2004 | 184 |
About Mohammad Obaidul Hoque
Mohammad Obaidul Hoque is a scholar working on Cancer Research, Molecular Biology, Otorhinolaryngology, Urology and Oncology, having authored 133 papers that have together received 8.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (62 papers), Cancer-related gene regulation (35 papers), Bladder and Urothelial Cancer Treatments (26 papers), RNA modifications and cancer (23 papers), Cancer Genomics and Diagnostics (13 papers), Urinary and Genital Oncology Studies (9 papers), Mitochondrial Function and Pathology (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (5.9k citations), Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Otorhinolaryngology (177 citations). Mohammad Obaidul Hoque has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include David Sidransky, Joseph A. Califano, Mariana Brait, William H. Westra, Cármen Jerónimo, Eli Rosenbaum, Shahnaz Begum, Rui Henrique, Sunil Upadhyay and Chulso Moon. Their work appears in journals such as Cancer Research, Clinical Cancer Research, International Journal of Cancer, PLoS ONE and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.